BVI Launches CryoTreq for Treatment of Retinal Tears and Detachments
06/04/2020
BVI announced the European launch of CryoTreq—a single-use, handheld cryosurgery device for ophthalmology. The device functions without external connections to equipment, gas tanks, or power and does not require any service or maintenance.
CryoTreq enables a minimally invasive ab externo approach to treat retinal tears and detachments, providing an alternative to laser photocoagulation—especially for lesions located towards the anterior of the eye. Like existing cryo equipment, CryoTreq’s probe reaches temperatures as low as -88⁰C and the tip reaches cryogenic temperatures within 4 to 6 seconds after activation.
BVI is actively working on registrations in jurisdictions outside of Europe.